Literature DB >> 10614880

The Harris-Galante uncemented femoral component in primary total hip replacement at 10 years.

J C Clohisy1, W H Harris.   

Abstract

Eighty-eight primary femoral reconstructions in 80 patients were performed with the Harris-Galante uncemented femoral stem by 1 surgeon between March 1984 and December 1987. Seventy-seven femoral components in 72 patients were followed for an average 126 months or until femoral revisions. The average age at operation was 54 years (range, 30-70 years). Fifty-two patients were men, and 20 were women. The present article documents the incidence of femoral osteolysis and femoral revision in this series of this type of femoral component at an average of 10 years. Fifteen femoral components (15 of 77, 19%) were revised, 14 (14 of 77, 18%) for aseptic loosening, osteolysis, or fracture through osteolysis. The remaining 62 femoral components were functioning well (average Harris Hip Score 89 points), but 7 (11%) were loose, and 32 (52%) had femoral endosteal lysis. Overall, 19 (25%) were revised or loose, and 46 (46 of 77, 60%) had lysis. The high incidence of femoral lysis and aseptic loosening with this early design of uncemented femoral stem continues to increase at 10-year follow-up.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10614880     DOI: 10.1016/s0883-5403(99)90003-7

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  13 in total

1.  [Cementless stems of the hip. Current status].

Authors:  H Effenberger; M Imhof; U Witzel; S Rehart
Journal:  Orthopade       Date:  2005-05       Impact factor: 1.087

2.  High survival of uncemented proximally porous-coated titanium alloy femoral stems in osteoporotic bone.

Authors:  John B Meding; Matthew R Galley; Merrill A Ritter
Journal:  Clin Orthop Relat Res       Date:  2009-09-01       Impact factor: 4.176

3.  Thirteen year follow-up of a cementless femoral stem and a threaded acetabular cup in patients younger than fifty years of age.

Authors:  Jan Schmolders; Grigoris Amvrazis; Peter H Pennekamp; Andreas Christian Strauss; Max Julian Friedrich; Matthias D Wimmer; Yorck Rommelspacher; Dieter Christian Wirtz; Thomas Wallny
Journal:  Int Orthop       Date:  2016-05-30       Impact factor: 3.075

4.  Effect of stem alignment on long-term outcomes of total hip arthroplasty with cementless Bi-Metric femoral components.

Authors:  Takaaki Shishido; Toshiyuki Tateiwa; Yasuhito Takahashi; Toshinori Masaoka; Tsunehito Ishida; Kengo Yamamoto
Journal:  J Orthop       Date:  2018-01-16

5.  A concise minimum eight year follow-up of proximally porous-coated tapered titanium femoral stem in primary total hip arthroplasty.

Authors:  Benjamin Beecher; Philip Glassner; Henrik Malchau; Young-Min Kwon
Journal:  Int Orthop       Date:  2012-03-14       Impact factor: 3.075

6.  Long-term (20- to 25-year) results of an uncemented tapered titanium femoral component and factors affecting survivorship.

Authors:  Marcus R Streit; Moritz M Innmann; Christian Merle; Thomas Bruckner; Peter R Aldinger; Tobias Gotterbarm
Journal:  Clin Orthop Relat Res       Date:  2013-05-14       Impact factor: 4.176

Review 7.  Femoral osteolysis following total hip replacement.

Authors:  R Dattani
Journal:  Postgrad Med J       Date:  2007-05       Impact factor: 2.401

8.  The John Charnley Award: Metal-on-metal hip resurfacing versus large-diameter head metal-on-metal total hip arthroplasty: a randomized clinical trial.

Authors:  Donald S Garbuz; Michael Tanzer; Nelson V Greidanus; Bassam A Masri; Clive P Duncan
Journal:  Clin Orthop Relat Res       Date:  2009-08-21       Impact factor: 4.176

9.  Mid-term results of an uncemented tapered femoral stem and various factors affecting survivorship.

Authors:  Mayank Vijayvargiya; Vivek Shetty; Kiran Makwana; Harpreet Singh Suri
Journal:  J Clin Orthop Trauma       Date:  2018-02-05

10.  Long-term follow-up results of a second-generation cementless femoral prosthesis with a collar and straight distal fixation channels.

Authors:  Chang Wook Han; Ick Hwan Yang; Hye Yeon Lee; Chang Dong Han
Journal:  Yonsei Med J       Date:  2012-01       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.